258 related articles for article (PubMed ID: 18780835)
1. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
[TBL] [Abstract][Full Text] [Related]
2. CXCL13-mediated recruitment of intrahepatic CXCR5
Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
[TBL] [Abstract][Full Text] [Related]
4. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
[TBL] [Abstract][Full Text] [Related]
5. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
[TBL] [Abstract][Full Text] [Related]
6. The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism.
Heinrichs M; Ashour D; Siegel J; Büchner L; Wedekind G; Heinze KG; Arampatzi P; Saliba AE; Cochain C; Hofmann U; Frantz S; Campos Ramos G
Cardiovasc Res; 2021 Nov; 117(13):2664-2676. PubMed ID: 34048536
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
Hussain SK; Zhu W; Chang SC; Breen EC; Vendrame E; Magpantay L; Widney D; Conn D; Sehl M; Jacobson LP; Bream JH; Wolinsky S; Rinaldo CR; Ambinder RF; Detels R; Zhang ZF; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):295-307. PubMed ID: 23250934
[TBL] [Abstract][Full Text] [Related]
8. CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.
Chunsong H; Yuling H; Li W; Jie X; Gang Z; Qiuping Z; Qingping G; Kejian Z; Li Q; Chang AE; Youxin J; Jinquan T
J Immunol; 2006 Nov; 177(10):6713-22. PubMed ID: 17082584
[TBL] [Abstract][Full Text] [Related]
9. Altered Expression of CXCL13 and Its Chemokine Receptor CXCR5 on B Lymphocytes during Active Graves' Orbitopathy.
Wan S; Lin M; Mao Y; Chen X; Liang D
Curr Eye Res; 2021 Feb; 46(2):210-216. PubMed ID: 32643429
[TBL] [Abstract][Full Text] [Related]
10. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.
Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A
Fluids Barriers CNS; 2021 Aug; 18(1):40. PubMed ID: 34446066
[TBL] [Abstract][Full Text] [Related]
11. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
[TBL] [Abstract][Full Text] [Related]
12. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
[TBL] [Abstract][Full Text] [Related]
13. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.
Trolese MC; Mariani A; Terao M; de Paola M; Fabbrizio P; Sironi F; Kurosaki M; Bonanno S; Marcuzzo S; Bernasconi P; Trojsi F; Aronica E; Bendotti C; Nardo G
EBioMedicine; 2020 Dec; 62():103097. PubMed ID: 33161233
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
[TBL] [Abstract][Full Text] [Related]
15. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
16. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics.
Sáez de Guinoa J; Barrio L; Mellado M; Carrasco YR
Blood; 2011 Aug; 118(6):1560-9. PubMed ID: 21659539
[TBL] [Abstract][Full Text] [Related]
17. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
[TBL] [Abstract][Full Text] [Related]
18. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
Barroso R; Martínez Muñoz L; Barrondo S; Vega B; Holgado BL; Lucas P; Baíllo A; Sallés J; Rodríguez-Frade JM; Mellado M
FASEB J; 2012 Dec; 26(12):4841-54. PubMed ID: 22913878
[TBL] [Abstract][Full Text] [Related]
19. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
[TBL] [Abstract][Full Text] [Related]
20. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.
Li Y; Wang W; Tang L; He X; Yan X; Zhang X; Zhu Y; Sun J; Shi Y; Ma X; Mackay IR; Gershwin ME; Han Y; Hou J
Hepatology; 2015 Jun; 61(6):1998-2007. PubMed ID: 25627620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]